The extracellular matrix in pancreatic cancer: description of a complex network and promising therapeutic options

B Ferrara, C Pignatelli, M Cossutta, A Citro, J Courty… - Cancers, 2021 - mdpi.com
Simple Summary This review depicts the principal mechanisms involved in the process of
stromal desmoplasia characterizing pancreatic ductal adenocarcinoma (PDAC). The aim of …

[HTML][HTML] 3D approaches to model the tumor microenvironment of pancreatic cancer

E Tomás-Bort, M Kieler, S Sharma, JB Candido… - Theranostics, 2020 - ncbi.nlm.nih.gov
In tumor engineering, 3D approaches are used to model components of the tumor
microenvironment and to test new treatments. Pancreatic cancers are a cancer of substantial …

RETRACTED ARTICLE: The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA

Z Feng, K Li, K Qin, J Liang, M Shi, Y Ma… - Journal of hematology & …, 2022 - Springer
Background Although a substantial increase in the survival of patients with other cancers
has been observed in recent decades, pancreatic ductal adenocarcinoma (PDAC) remains …

Stroma involvement in pancreatic ductal adenocarcinoma: An overview focusing on extracellular matrix proteins

S Liot, J Balas, A Aubert, L Prigent… - Frontiers in …, 2021 - frontiersin.org
Pancreatic cancer is the seventh leading cause of cancer-related deaths worldwide and is
predicted to become second in 2030 in industrialized countries if no therapeutic progress is …

EMT and stemness—Key players in pancreatic cancer stem cells

E Rodriguez-Aznar, L Wiesmüller, B Sainz Jr… - Cancers, 2019 - mdpi.com
Metastasis and tumor progression are the major cause of death in patients suffering from
pancreatic ductal adenocarcinoma. Tumor growth and especially dissemination are typically …

Targeting tumor-stromal interactions in pancreatic cancer: impact of collagens and mechanical traits

P Maneshi, J Mason, M Dongre… - Frontiers in Cell and …, 2021 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) has one of the worst outcomes among cancers
with a 5-years survival rate of below 10%. This is a result of late diagnosis and the lack of …

LAMB3 promotes tumour progression through the AKT–FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer

Z Zhu, J Song, Y Guo, Z Huang, X Chen, X Dang… - Oncogene, 2020 - nature.com
Aberrant expression of laminin-332 promotes tumour growth and metastasis in multiple
cancers. However, the dysregulated expression and mechanism of action of LAMB3, which …

Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients

W Li, T Li, C Sun, Y Du, L Chen, C Du, J Shi… - Molecular Medicine, 2022 - Springer
Background Pancreatic cancer (PC) is a malignancy with a poor prognosis and high
mortality. Surgical resection is the only “curative” treatment. However, only a minority of …

Identification of potential biomarkers and survival analysis for head and neck squamous cell carcinoma using bioinformatics strategy: a study based on TCGA and …

Y Shen, J Liu, L Zhang, S Dong, J Zhang… - BioMed research …, 2019 - Wiley Online Library
The mechanism and gene markers of head and neck squamous cell carcinoma (HNSCC), a
common malignant tumor, have not yet been identified. The aim of this study was to identify …

TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway

DH Huang, J Jian, S Li, Y Zhang… - … Journal of Molecular …, 2019 - spandidos-publications.com
Hepatocellular carcinoma (HCC) is one of the primary causes of cancer‑associated deaths
worldwide. Current treatment methods include surgical resection, chemotherapy and …